| __timestamp | Biogen Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 8532288000 | 1162636000 |
| Thursday, January 1, 2015 | 9523400000 | 1396725000 |
| Friday, January 1, 2016 | 9970100000 | 1526100000 |
| Sunday, January 1, 2017 | 10643900000 | 1619600000 |
| Monday, January 1, 2018 | 11636600000 | 1429100000 |
| Tuesday, January 1, 2019 | 12422500000 | 1331200000 |
| Wednesday, January 1, 2020 | 11639400000 | 1375200000 |
| Friday, January 1, 2021 | 8872000000 | 1563000000 |
| Saturday, January 1, 2022 | 7895100000 | 1789600000 |
| Sunday, January 1, 2023 | 7302200000 | 2070000000 |
| Monday, January 1, 2024 | 9675900000 |
Data in motion
In the ever-evolving landscape of biotechnology, understanding financial health is crucial. This analysis delves into the gross profit trends of Biogen Inc. and United Therapeutics Corporation from 2014 to 2023. Over this period, Biogen's gross profit peaked in 2019, showcasing a robust 46% increase from 2014. However, a notable decline followed, with a 41% drop by 2023. In contrast, United Therapeutics demonstrated a steady upward trajectory, achieving a 78% growth in gross profit by 2023. This divergence highlights Biogen's recent challenges and United Therapeutics' consistent growth strategy. The data underscores the importance of strategic adaptability in the biotech sector, where market dynamics and innovation drive financial outcomes. As we look to the future, these trends offer valuable insights into the competitive landscape and potential investment opportunities.
Gross Profit Comparison: Eli Lilly and Company and United Therapeutics Corporation Trends
Key Insights on Gross Profit: AbbVie Inc. vs Biogen Inc.
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Biogen Inc.
Bristol-Myers Squibb Company vs United Therapeutics Corporation: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: GSK plc vs United Therapeutics Corporation
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Who Generates Higher Gross Profit? Biogen Inc. or Genmab A/S
Key Insights on Gross Profit: Biogen Inc. vs Dr. Reddy's Laboratories Limited
Gross Profit Analysis: Comparing Biogen Inc. and Supernus Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Genmab A/S
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown